U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
160711160711Study of the Effects of Mecamylamine and Varenicline in SchizophreniaCompletedNo Results AvailableCognition in SchizophreniaDrug: Mecamylamine|Drug: Varenicline|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00455650
160712160712Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?TerminatedNo Results AvailableCerebral PalsyDrug: Botulinum type A toxin (Dysport®)https://ClinicalTrials.gov/show/NCT00455637
160713160713Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate CancerCompletedNo Results AvailableProstate CancerDrug: Androgen deprivation therapyhttps://ClinicalTrials.gov/show/NCT00455624
160714160714Effects of CPAP on Ventricular Function ModificationsWithdrawnNo Results AvailableHeart Failure, CongestiveDevice: CPAP (Continuous Positive Airway Pressure)https://ClinicalTrials.gov/show/NCT00455611
160715160715Placebo Controlled, Dose Escalation Study in Subjects With Type 2 Diabetes Mellitus Being Treated With SulfonylureaCompletedNo Results AvailableType 2 Diabetes MellitusDrug: ISIS 113715https://ClinicalTrials.gov/show/NCT00455598
160716160716Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator ProductsCompletedNo Results AvailableHIV InfectionsDrug: nevirapine, stavudine, lamivudinehttps://ClinicalTrials.gov/show/NCT00455585
160717160717Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung CancerTerminatedNo Results AvailableLung Cancer, Non-Small CellBiological: Immunotherapeutic GSK1572932A|Drug: Cisplatin (CDDP)|Drug: Vinorelbine|Procedure: Radiotherapyhttps://ClinicalTrials.gov/show/NCT00455572
160718160718Ph II Study of Perifosine Plus Gleevec for Patients With GISTCompletedNo Results AvailableGastrointestinal Stromal TumorsDrug: Perifosine|Drug: Imatinib Mesylatehttps://ClinicalTrials.gov/show/NCT00455559
160719160719PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery DiseaseCompletedNo Results AvailableCoronary Artery Disease (CAD)Drug: A-002https://ClinicalTrials.gov/show/NCT00455546
160720160720Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast CancerCompletedHas ResultsBreast CancerDrug: Ixabepilone|Drug: Paclitaxel|Drug: Cyclophosphamide|Drug: Doxorubicinhttps://ClinicalTrials.gov/show/NCT00455533
160721160721A Safety and Efficacy Study for Tapentadol (CG5503) Extended Release for Patients With Painful Diabetic Peripheral NeuropathyCompletedHas ResultsDiabetic NeuropathyDrug: CG5503|Drug: placebohttps://ClinicalTrials.gov/show/NCT00455520
160722160722A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking LevodopaCompletedNo Results AvailableParkinson's DiseaseDrug: Istradefylline|Drug: Istradefylline|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00455507
160723160723Food-Effect Bioavailability Study of AQ-13, a Candidate AntimalarialRecruitingNo Results AvailableMalariaDrug: AQ-13https://ClinicalTrials.gov/show/NCT00455494
160724160724Randomized Controlled Trial (RCT) in Children With Severe PneumoniaCompletedNo Results AvailableSevere PneumoniaProcedure: Day-care treatment vs. hospital carehttps://ClinicalTrials.gov/show/NCT00455468
160725160725Corneal and Conjunctival Sensitivity and Staining StudyCompletedHas ResultsMyopia|HyperopiaDrug: Optifree RepleniSH Multipurpose Disinfecting Solution|Drug: ReNu Multiplus Multipurpose Solutionhttps://ClinicalTrials.gov/show/NCT00455455
160726160726A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight GainCompletedNo Results AvailableWeight-Gain PreventionDrug: Mifepristonehttps://ClinicalTrials.gov/show/NCT00455442
160727160727An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic DermatitisTerminatedHas ResultsAtopic DermatitisDrug: Placebo|Drug: JNJ-26113100 (50 mg) once daily|Drug: JNJ-26113100 (100 mg) once daily|Drug: JNJ-26113100 (100 mg) twice daily|Drug: JNJ-26113100 (250 mg) twice dailyhttps://ClinicalTrials.gov/show/NCT00455429
160728160728Dietary Intervention in Follicular LymphomaRecruitingNo Results AvailableFollicular LymphomaDrug: Omega 3 fatty acids (EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid))|Drug: Selenium (L-Selenomethionine),|Drug: Garlic extract (Allicin)|Drug: Pomegranate juice (ellagic acid)|Drug: Grape juice (resveratrol, quercetin)|Drug: Green Tea (Epigallocathechin gallate)https://ClinicalTrials.gov/show/NCT00455416
160729160729Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)Active, not recruitingNo Results AvailableMetabolic Syndrome X|Overweight|Hypertension|Dyslipidemias|Prediabetic StateDrug: Chloroquine|Drug: Placebo Comparatorhttps://ClinicalTrials.gov/show/NCT00455403
160730160730Evaluation of the Effects of Post-Immediate Psychotherapeutic Interventions in Secondary Prevention of Psychotraumatic DisordersRecruitingNo Results AvailablePTSD Post Traumatic Syndrome DisorderProcedure: Post-immediate Psychotherapeutic Interventionhttps://ClinicalTrials.gov/show/NCT00455390
160731160731Lung Function and Airway Inflammation in Portland Cement WorkersCompletedNo Results AvailableAirway Inflammation|Peripheral Blood Inflammation Markers|Cement Dust Exposurehttps://ClinicalTrials.gov/show/NCT00455377
160732160732Voriconazole as Prophylactic Therapy in Lung Transplant RecipientsTerminatedNo Results AvailableInfectionDrug: Voriconazolehttps://ClinicalTrials.gov/show/NCT00455364
160733160733Vorinostat and Palliative RadiotherapyCompletedNo Results AvailablePelvic Cancer|RadiotherapyDrug: Vorinostathttps://ClinicalTrials.gov/show/NCT00455351
160734160734Effect of Meal Composition on Postprandial Testosterone Concentration in Women With Polycystic Ovary SyndromeCompletedNo Results AvailablePolycystic Ovary SyndromeBehavioral: Meal Compositionhttps://ClinicalTrials.gov/show/NCT00455338
160735160735Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)Active, not recruitingNo Results AvailableMetabolic Syndrome X|Overweight|Hypertension|Dyslipidemias|Prediabetic StateDrug: Placebo Comparator Limb 1|Drug: Chloroquine|Drug: Chloroquine|Drug: Chloroquinehttps://ClinicalTrials.gov/show/NCT00455325
160736160736SCT for Dyskeratosis Congenita or SAAActive, not recruitingNo Results AvailableDyskeratosis Congenita|Aplastic AnemiaDrug: Campath 1H|Drug: Cyclophosphamide|Drug: Fludarabine|Procedure: Total Body Irradiation|Procedure: Stem Cell Transplantation|Drug: antithymocyte globulin|Drug: Methylprednisolonehttps://ClinicalTrials.gov/show/NCT00455312
160737160737LVHR Multicenter StudyCompletedNo Results AvailableVentral and Ventral Insicional HerniaProcedure: Laparoscopic ventral hernia repairhttps://ClinicalTrials.gov/show/NCT00455299
160738160738a Phase II Study in Primary Central Nervous System LymphomaRecruitingNo Results AvailablePrimary Central Nervous System LymphomaDrug: Methotrexate|Drug: Methylprednisolone|Drug: Temozolomidehttps://ClinicalTrials.gov/show/NCT00455286
160739160739Dynamic Breast MRI in Assessing Locally Advanced Breast CancerRecruitingNo Results AvailableLocally Advanced Breast Cancerhttps://ClinicalTrials.gov/show/NCT00455273
160740160740A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDermâ„¢ System in Adults With GH-DeficiencyCompletedNo Results AvailableGrowth Hormone DeficiencyDrug: hGH-ViaDermâ„¢ System (hGH or somatropin)|Device: hGH-ViaDermâ„¢ Systemhttps://ClinicalTrials.gov/show/NCT00455260

* Görseller ve İçerik tekif hakkına sahip olabilir